Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years

被引:0
作者
Barallakos, X.
Brandt, J.
Listing, J.
Sieper, J.
Braun, J.
机构
[1] Rheumatol Med Ctr Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Univ Med Berlin, Berlin, Germany
关键词
Infliximab; Ankylose Spondylitis; Open Label Extension; Infliximab Treatment; Relevant Side Effect;
D O I
10.1186/ar1550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S14 / S14
页数:1
相关论文
empty
未找到相关数据